This is a Validated Antibody Database (VAD) review about mouse Zeb1, based on 48 published articles (read how Labome selects the articles), using Zeb1 antibody in all methods. It is aimed to help Labome visitors find the most suited Zeb1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Zeb1 synonym: 3110032K11Rik; AREB6; BZP; MEB1; Nil2; TCF-8; Tcf18; Tcf8; Tw; ZEB; Zfhep; Zfhx1a; Zfx1a; Zfx1ha; [delta]EF1

Invitrogen
mouse monoclonal (3G6)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s4c
Invitrogen Zeb1 antibody (eBioscience, 14-9741-82) was used in immunohistochemistry - paraffin section on mouse samples (fig s4c). Cell (2019) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in western blot on human samples (fig 5b). Transl Oncol (2022) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; fig 10c
Cell Signaling Technology Zeb1 antibody (CST, 3396) was used in western blot on human samples (fig 10c). Sci Adv (2021) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 6c, 6f
Cell Signaling Technology Zeb1 antibody (CST, 3396) was used in western blot on human samples (fig 6c, 6f). Mol Ther Nucleic Acids (2021) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; loading ...; fig 6b
Cell Signaling Technology Zeb1 antibody (Cell Signaling Technology, 3396) was used in western blot on human samples at 1:1000 (fig 6b). Commun Biol (2021) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; fig 3h
Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in western blot on human samples at 1:1000 (fig 3h). Commun Biol (2021) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; loading ...; fig 2g: 2h, 2i
Cell Signaling Technology Zeb1 antibody (CST, 3396) was used in western blot on human samples at 1:1000 (fig 2g: 2h, 2i). Am J Cancer Res (2020) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology Zeb1 antibody (Cell Signaling Technology, 3396) was used in western blot on human samples (fig 5a). Oncogene (2020) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; loading ...; fig 4f
Cell Signaling Technology Zeb1 antibody (Cell Signaling Technology, 3396S) was used in western blot on human samples at 1:1000 (fig 4f). Cell Death Dis (2019) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; loading ...; fig 4b, s1b
Cell Signaling Technology Zeb1 antibody (CST, 3396S) was used in western blot on human samples at 1:1000 (fig 4b, s1b). Biol Open (2019) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology Zeb1 antibody (CST, 3396) was used in western blot on human samples (fig 2a). Cell Commun Signal (2019) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology Zeb1 antibody (CST, 3396) was used in western blot on human samples (fig 3d). J Exp Clin Cancer Res (2019) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; loading ...; fig 4c
Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in western blot on human samples at 1:1000 (fig 4c). BMC Cancer (2019) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology Zeb1 antibody (Cell Signaling Technology, 3396) was used in western blot on human samples (fig 2a). elife (2019) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:500; loading ...; fig s2a
Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in western blot on human samples at 1:500 (fig s2a). Sci Adv (2019) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in western blot on human samples (fig 3b). J Cell Mol Med (2018) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; fig s6i
Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in western blot on human samples at 1:1000 (fig s6i). Nat Commun (2017) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; loading ...; fig 7j
Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in western blot on human samples at 1:1000 (fig 7j). J Clin Invest (2017) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; loading ...; fig ex7b
Cell Signaling Technology Zeb1 antibody (Cell signaling, D80D3) was used in western blot on human samples at 1:1000 (fig ex7b). Nature (2017) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 2e
In order to investigate the effect off miR-509-5p and miR-1243 on gemcitabine efficacy in pancreatic cancer and its mechanism, Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in western blot on human samples (fig 2e). Sci Rep (2017) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; loading ...
In order to identify conditions in which low-passage ARPE-19 cells express genes specific to native human RPE cells, Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in western blot on human samples at 1:1000. Mol Vis (2017) ncbi
domestic rabbit monoclonal (D80D3)
  • immunocytochemistry; human; 1:100; fig 3b
In order to investigate how LACTB suppresses breast cancer cell growth, Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in immunocytochemistry on human samples at 1:100 (fig 3b). Nature (2017) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; loading ...; fig 6d
Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in western blot on human samples at 1:1000 (fig 6d). Int J Mol Med (2017) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...
Cell Signaling Technology Zeb1 antibody (Cell Signaling Technology, 3396) was used in western blot on human samples . Neoplasia (2017) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 7d
Cell Signaling Technology Zeb1 antibody (Cell Signalling, 3396) was used in western blot on human samples (fig 7d). Nucleic Acids Res (2016) ncbi
domestic rabbit monoclonal (D80D3)
  • immunohistochemistry; mouse; loading ...; fig 8l
Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in immunohistochemistry on mouse samples (fig 8l). Oncogene (2017) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; fig s3b
Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in western blot on human samples at 1:1000 (fig s3b). Science (2016) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 6a
Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in western blot on human samples (fig 6a). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; fig 5
Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in western blot on human samples (fig 5). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; fig 2
Cell Signaling Technology Zeb1 antibody (Cell Signaling, D80D3) was used in western blot on human samples at 1:1000 (fig 2). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; fig 6
Cell Signaling Technology Zeb1 antibody (Cell signaling, 3396) was used in western blot on human samples (fig 6). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 8b
Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in western blot on human samples (fig 8b). Nat Commun (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; mouse; fig 1d
In order to test if ZO-1-mediated diminution of polarity results in an epithelial-to-mesenchyme transition and increased metastatic potential, Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in western blot on mouse samples (fig 1d). Oncogene (2016) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; fig 7a
In order to demonstrate that LRIG1 functions as a growth suppressor in breast cancer cells, Cell Signaling Technology Zeb1 antibody (Cell Signaling Technology, 3396) was used in western blot on human samples (fig 7a). Oncogene (2016) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; fig 5
Cell Signaling Technology Zeb1 antibody (Cell Signaling, D80D3) was used in western blot on human samples at 1:1000 (fig 5). Nucleic Acids Res (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; fig 2
Cell Signaling Technology Zeb1 antibody (Cell signaling, 3396) was used in western blot on human samples at 1:1000 (fig 2). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • other; human; loading ...; fig 4a, 4d
Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in other on human samples (fig 4a, 4d). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; fig 3
Cell Signaling Technology Zeb1 antibody (Cell Signaling Technology, 3396) was used in western blot on human samples (fig 3). Sci Rep (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • immunohistochemistry - paraffin section; mouse
  • western blot; mouse
In order to investigate the effect of miR-200c on claudin-low breast cancer, Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in immunohistochemistry - paraffin section on mouse samples and in western blot on mouse samples . Oncogene (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; fig 3
In order to elucidate the tumor suppressor function of BTG3, Cell Signaling Technology Zeb1 antibody (Cell Signaling Technologies, 3396) was used in western blot on human samples (fig 3). Cell Death Dis (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • immunocytochemistry; human
Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in immunocytochemistry on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; fig 3
In order to investigate the roles and mechanisms of the RSPO-LGR system in oncogenesis, Cell Signaling Technology Zeb1 antibody (Cell Signaling Technology, 3396) was used in western blot on human samples (fig 3). Oncogene (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; fig 1
Cell Signaling Technology Zeb1 antibody (Cell signaling, 3396) was used in western blot on human samples (fig 1). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human
In order to study how phosphorylation alters COP1-binding sites of oncoproteins, Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396) was used in western blot on human samples . Cancer Cell (2014) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human
Cell Signaling Technology Zeb1 antibody (Cell Signaling Technology, 3396) was used in western blot on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; mouse; fig 2e
In order to show that Basonuclin-1 regulates TGF-beta1-induced epithelial dedifferentiation of mammary epithelial cells, Cell Signaling Technology Zeb1 antibody (Cell Signaling Technologies, 3396) was used in western blot on mouse samples (fig 2e). Oncogene (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human
Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396p) was used in western blot on human samples . Cancer Res (2014) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human
Cell Signaling Technology Zeb1 antibody (Cell Signaling, 3396S) was used in western blot on human samples . PLoS ONE (2013) ncbi
Articles Reviewed
  1. Yang J, Liao Q, Price M, Moriarity B, Wolf N, Felices M, et al. Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation. Transl Oncol. 2022;16:101318 pubmed publisher
  2. Li K, Wu R, Zhou M, Tong H, Luo K. Desmosomal proteins of DSC2 and PKP1 promote cancer cells survival and metastasis by increasing cluster formation in circulatory system. Sci Adv. 2021;7:eabg7265 pubmed publisher
  3. Sun Z, Sun D, Feng Y, Zhang B, Sun P, Zhou B, et al. Exosomal linc-ROR mediates crosstalk between cancer cells and adipocytes to promote tumor growth in pancreatic cancer. Mol Ther Nucleic Acids. 2021;26:253-268 pubmed publisher
  4. Kariya Y, Oyama M, Suzuki T, Kariya Y. αvβ3 Integrin induces partial EMT independent of TGF-β signaling. Commun Biol. 2021;4:490 pubmed publisher
  5. Hu X, Villodre E, Larson R, Rahal O, Wang X, Gong Y, et al. Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer. Commun Biol. 2021;4:72 pubmed publisher
  6. Li M, Wu P, Yang Z, Deng S, Ni L, Zhang Y, et al. miR-193a-5p promotes pancreatic cancer cell metastasis through SRSF6-mediated alternative splicing of OGDHL and ECM1. Am J Cancer Res. 2020;10:38-59 pubmed
  7. Chen X, Xiong X, Cui D, Yang F, Wei D, Li H, et al. DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals. Oncogene. 2020;39:1557-1571 pubmed publisher
  8. Tan P, Xu Y, Du Y, Wu L, Guo B, Huang S, et al. SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG. Cell Death Dis. 2019;10:794 pubmed publisher
  9. Tian M, Gong W, Guo J. Long non-coding RNA SNHG1 indicates poor prognosis and facilitates disease progression in acute myeloid leukemia. Biol Open. 2019;8: pubmed publisher
  10. Jiang S, Zhang M, Zhang Y, Zhou W, Zhu T, Ruan Q, et al. WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling. Cell Commun Signal. 2019;17:109 pubmed publisher
  11. Li Q, Lai Q, He C, Fang Y, Yan Q, Zhang Y, et al. RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer. J Exp Clin Cancer Res. 2019;38:334 pubmed publisher
  12. Smestad J, Maher L. Master regulator analysis of paragangliomas carrying SDHx, VHL, or MAML3 genetic alterations. BMC Cancer. 2019;19:619 pubmed publisher
  13. Adams C, Htwe H, Marsh T, Wang A, Montoya M, Subbaraj L, et al. Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer. elife. 2019;8: pubmed publisher
  14. Sonego M, Pellarin I, Costa A, Vinciguerra G, Coan M, Kraut A, et al. USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability. Sci Adv. 2019;5:eaav3235 pubmed publisher
  15. Sharon N, Chawla R, Mueller J, Vanderhooft J, Whitehorn L, Rosenthal B, et al. A Peninsular Structure Coordinates Asynchronous Differentiation with Morphogenesis to Generate Pancreatic Islets. Cell. 2019;176:790-804.e13 pubmed publisher
  16. Vl kov K, Vachtenheim J, R da J, Hor k P, Ondru ov L. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells. J Cell Mol Med. 2018;22:2240-2251 pubmed publisher
  17. Wang J, Ye Q, Cao Y, Guo Y, Huang X, Mi W, et al. Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1. Nat Commun. 2017;8:2207 pubmed publisher
  18. Caino M, Seo J, Wang Y, Rivadeneira D, Gabrilovich D, Kim E, et al. Syntaphilin controls a mitochondrial rheostat for proliferation-motility decisions in cancer. J Clin Invest. 2017;127:3755-3769 pubmed publisher
  19. Viswanathan V, Ryan M, Dhruv H, Gill S, Eichhoff O, Seashore Ludlow B, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547:453-457 pubmed publisher
  20. Hiramoto H, Muramatsu T, Ichikawa D, Tanimoto K, Yasukawa S, Otsuji E, et al. miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer. Sci Rep. 2017;7:4002 pubmed publisher
  21. Samuel W, Jaworski C, Postnikova O, Kutty R, Duncan T, Tan L, et al. Appropriately differentiated ARPE-19 cells regain phenotype and gene expression profiles similar to those of native RPE cells. Mol Vis. 2017;23:60-89 pubmed
  22. Keckesova Z, Donaher J, De Cock J, Freinkman E, Lingrell S, Bachovchin D, et al. LACTB is a tumour suppressor that modulates lipid metabolism and cell state. Nature. 2017;543:681-686 pubmed publisher
  23. Li X, Liu W, Chen X, Wang Y, Shi D, Zhang H, et al. Overexpression of TMPRSS4 promotes tumor proliferation and aggressiveness in breast cancer. Int J Mol Med. 2017;39:927-935 pubmed publisher
  24. Zhai S, Liu C, Zhang L, Zhu J, Guo J, Zhang J, et al. PLCE1 Promotes Esophageal Cancer Cell Progression by Maintaining the Transcriptional Activity of Snail. Neoplasia. 2017;19:154-164 pubmed publisher
  25. Fletcher C, Godfrey J, Shibakawa A, Bushell M, Bevan C. A novel role for GSK3? as a modulator of Drosha microprocessor activity and MicroRNA biogenesis. Nucleic Acids Res. 2016;: pubmed
  26. Zhang Q, Liu S, Parajuli K, Zhang W, Zhang K, Mo Z, et al. Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition. Oncogene. 2017;36:687-699 pubmed publisher
  27. Pattabiraman D, Bierie B, Kober K, Thiru P, Krall J, Zill C, et al. Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability. Science. 2016;351:aad3680 pubmed publisher
  28. Chung V, Tan T, Tan M, Wong M, Kuay K, Yang Z, et al. GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification. Sci Rep. 2016;6:19943 pubmed publisher
  29. Haraguchi T, Kondo M, Uchikawa R, Kobayashi K, Hiramatsu H, Kobayashi K, et al. Dynamics and plasticity of the epithelial to mesenchymal transition induced by miR-200 family inhibition. Sci Rep. 2016;6:21117 pubmed publisher
  30. Fazio C, Piazzi G, Vitaglione P, Fogliano V, Munarini A, Prossomariti A, et al. Inflammation increases NOTCH1 activity via MMP9 and is counteracted by Eicosapentaenoic Acid-free fatty acid in colon cancer cells. Sci Rep. 2016;6:20670 pubmed publisher
  31. Wang F, Feng Y, Li P, Wang K, Feng L, Liu Y, et al. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma. Oncotarget. 2016;7:4279-97 pubmed publisher
  32. Chen C, Zhu C, Huang J, Zhao X, Deng R, Zhang H, et al. SUMOylation of TARBP2 regulates miRNA/siRNA efficiency. Nat Commun. 2015;6:8899 pubmed publisher
  33. Nagaoka K, Fujii K, Zhang H, Usuda K, Watanabe G, Ivshina M, et al. CPEB1 mediates epithelial-to-mesenchyme transition and breast cancer metastasis. Oncogene. 2016;35:2893-901 pubmed publisher
  34. Yokdang N, Hatakeyama J, Wald J, Simion C, Tellez J, Chang D, et al. LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells. Oncogene. 2016;35:2932-47 pubmed publisher
  35. Zhu C, Chen C, Huang J, Zhang H, Zhao X, Deng R, et al. SUMOylation at K707 of DGCR8 controls direct function of primary microRNA. Nucleic Acids Res. 2015;43:7945-60 pubmed publisher
  36. Zucha M, Wu A, Lee W, Wang L, Lin W, Yuan C, et al. Bruton's tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in ovarian cancer. Oncotarget. 2015;6:13255-68 pubmed
  37. Yamada A, Aki T, Unuma K, Funakoshi T, Uemura K. Paraquat induces epithelial-mesenchymal transition-like cellular response resulting in fibrogenesis and the prevention of apoptosis in human pulmonary epithelial cells. PLoS ONE. 2015;10:e0120192 pubmed publisher
  38. Lin Y, Yang Z, Xu A, Dong P, Huang Y, Liu H, et al. PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3β/CTNNB1 signaling pathway. Sci Rep. 2015;5:8997 pubmed publisher
  39. Knezevic J, Pfefferle A, Petrovic I, Greene S, Perou C, Rosen J. Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential. Oncogene. 2015;34:5997-6006 pubmed publisher
  40. Cheng Y, Chen P, Chiang H, Suen C, Hwang M, Lin T, et al. Candidate tumor suppressor B-cell translocation gene 3 impedes neoplastic progression by suppression of AKT. Cell Death Dis. 2015;6:e1584 pubmed publisher
  41. Tange S, Oktyabri D, Terashima M, Ishimura A, Suzuki T. JARID2 is involved in transforming growth factor-beta-induced epithelial-mesenchymal transition of lung and colon cancer cell lines. PLoS ONE. 2014;9:e115684 pubmed publisher
  42. Gong X, Yi J, Carmon K, Crumbley C, Xiong W, Thomas A, et al. Aberrant RSPO3-LGR4 signaling in Keap1-deficient lung adenocarcinomas promotes tumor aggressiveness. Oncogene. 2015;34:4692-701 pubmed publisher
  43. Xu M, Zhu C, Zhao X, Chen C, Zhang H, Yuan H, et al. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors. Oncotarget. 2015;6:979-94 pubmed
  44. Lu G, Zhang Q, Huang Y, Song J, Tomaino R, Ehrenberger T, et al. Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor. Cancer Cell. 2014;26:222-34 pubmed publisher
  45. Subramani R, Lopez Valdez R, Arumugam A, Nandy S, Boopalan T, Lakshmanaswamy R. Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis. PLoS ONE. 2014;9:e97016 pubmed publisher
  46. Feuerborn A, Mathow D, Srivastava P, Gretz N, Grone H. Basonuclin-1 modulates epithelial plasticity and TGF-?1-induced loss of epithelial cell integrity. Oncogene. 2015;34:1185-95 pubmed publisher
  47. Wu K, Chen K, Wang C, Jiao X, Wang L, Zhou J, et al. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation. Cancer Res. 2014;74:829-39 pubmed publisher
  48. Harazono Y, Muramatsu T, Endo H, Uzawa N, Kawano T, Harada K, et al. miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2. PLoS ONE. 2013;8:e62757 pubmed publisher